Home
Conditions
Lymphohistiocytosis, Hemophagocytic

Clinical trial condition

Lymphohistiocytosis, Hemophagocytic

Explore clinical trials studying Lymphohistiocytosis, Hemophagocytic. Study availability and eligibility vary by location and protocol.

65 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Lymphohistiocytosis, Hemophagocytic trial results

Not Yet Recruiting

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

NCT07660783

Conditions: Autoimmune Cytopenia, Bone Marrow Diseases, Bone Marrow Failure, +17 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis

NCT07626398

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis (HLH), Histiocytosis, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis

NCT07497438

Conditions: Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, +9 more
Locations: Intensive Care Unit - Avicenne Hospital, Assistance Publique des Hôpitaux de Paris Bobigny, France

View Trial Details

Not Yet Recruiting

Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis

NCT06951971

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis (HLH), Histiocytosis, +3 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

The Microbiome in Blood Cancer and HLH

NCT06734624

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Haemophagocytic Lymphohistiocytosis, +15 more
Locations: University of Nottingham Nottingham, Nottinghamshire, United Kingdom

View Trial Details

Not Yet Recruiting

Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis

NCT06504030

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

NCT06131489

Conditions: Bowel Resection, DNA Virus Infections, Epstein-Barr Virus, +11 more
Locations: Zhao Wang Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections

NCT05988177

Conditions: Carbapenem Resistant Bacterial Infection, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, +4 more
Locations: Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

NCT05775705

Conditions: DNA Virus Infections, Epstein-Barr Virus, Epstein-Barr Virus Infections, +17 more
Locations: Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Completed

Treatment of Familiar Lymphohistiocytosis

NCT02472054

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis (HLH), Histiocytosis, +3 more
Locations: Hôpital Necker-Enfants Malades Paris, France

View Trial Details

Lymphohistiocytosis, Hemophagocytic

Lymphohistiocytosis, Hemophagocytic trial results

Related conditions